Loading...
•
Mar 31, 2023
ClearPoint Neuro Q1 2023 Earnings Report
Reported an 8% increase in quarterly revenue year-over-year, driven by a 24% increase in biologics and drug delivery revenue.
Key Takeaways
ClearPoint Neuro reported a revenue of $5.4 million for Q1 2023, an 8% increase compared to Q1 2022. The company reaffirmed its full-year 2023 revenue outlook of $25.0 to $27.0 million.
Reported quarterly revenue of $5.4 million, an 8% year-over-year increase.
Increased biologics and drug delivery revenue to $2.7 million, a 24% year-over-year increase.
Installed two additional ClearPoint Navigation systems and two additional Prism Laser Therapy systems in the quarter.
Reaffirmed full year 2023 revenue outlook of between $25.0 and $27.0 million.
Revenue by Segment
Forward Guidance
The Company reaffirms its full year 2023 revenue outlook of between $25.0 and $27.0 million, representing 22% to 35% growth year over year.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...